Cadrenal Therapeutics, Inc. Common Stock (CVKD)

USD 12.96

(13.19%)

Annual Cash Flows

(In USD)
Breakdown 2023 2022
Operating Cash Flow -3.53 Million -1.2 Million
Net Income -8.35 Million -6.71 Million
Depreciation & Amortization 1980.00 1266.00
Deferred income taxes -951.91 Thousand -
Stock-based compensation 710.38 Thousand -
Change in working capital 144.3 Thousand 607.73 Thousand
Other non-cash items 4.92 Million 4.49 Million
Investing Cash Flow -3254.00 -2279.00
Investments in PPE -3254.00 -
Acquisitions - -
Investment purchases - -2279.00
Sales/Maturities of investments - -
Other Investing Activities - -
Financing Cash Flow 11.9 Million 1.23 Million
Debt repayment -250 Thousand -
Dividends payments - -
Common Stock Repurchased - -
Common Stock Issuance 12.15 Million 1.23 Million
Other Financing Activities 6.49 Million -
Accounts receivables - -
Accounts payables -237.57 Thousand 404.89 Thousand
Inventory - -
Other working capital 381.88 Thousand 202.83 Thousand
Cash at beginning of period 32.58 Thousand -1.00
Cash at end of period 8.4 Million 32.58 Thousand
Capital Expenditure -3254.00 -
Effect of forex changes on cash 1.00 -
Net cash flow / Change in cash 8.36 Million 32.58 Thousand
Free Cash Flow -3.53 Million -1.2 Million

Cash Flow Charts